SynthesisFrontiers in oncology2024

Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Yuxiang Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.